Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years-Reference-Cited by-同舟云学术

Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

Published:2020-08 Issue:2 Volume:204 Page:281-288
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Vertosick Emily A.¹,Häggström Christel²³,Sjoberg Daniel D.¹,Hallmans Göran⁴,Johansson Robert²,Vickers Andrew J.¹,Stattin Pär³,Lilja Hans⁵⁶⁷⁸

Affiliation:

1. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Biobank Research, Umeå University, Umeå, Sweden

3. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

4. Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden

5. Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York

6. Departments of Laboratory Medicine and Medicine (GU-Oncology Service), Memorial Sloan Kettering Cancer Center, New York, New York

7. Department of Translational Medicine, Lund University, Malmö, Sweden

8. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial;European Urology;2024-09

2. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06

3. Nanomedicine for Prostate Cancer Treatment;BioNanoScience;2024-05-28

4. Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI;JAMA;2024-05-07

5. Evolution of European prostate cancer screening protocols and summary of ongoing trials;BJU International;2024-03-12